R. Michael Tuttle

59.4k total citations · 6 hit papers
326 papers, 34.1k citations indexed

About

R. Michael Tuttle is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, R. Michael Tuttle has authored 326 papers receiving a total of 34.1k indexed citations (citations by other indexed papers that have themselves been cited), including 306 papers in Endocrinology, Diabetes and Metabolism, 157 papers in Surgery and 60 papers in Genetics. Recurrent topics in R. Michael Tuttle's work include Thyroid Cancer Diagnosis and Treatment (301 papers), Thyroid and Parathyroid Surgery (133 papers) and Head and Neck Anomalies (64 papers). R. Michael Tuttle is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (301 papers), Thyroid and Parathyroid Surgery (133 papers) and Head and Neck Anomalies (64 papers). R. Michael Tuttle collaborates with scholars based in United States, Italy and Canada. R. Michael Tuttle's co-authors include Susan J. Mandel, Steven I. Sherman, Bryan R. Haugen, Martin Schlumberger, Furio Pacini, David L. Steward, Gerard M. Doherty, Gregory W. Randolph, Ashok R. Shaha and Leonard Wartofsky and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

R. Michael Tuttle

314 papers receiving 33.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

2015 10.0k citations R. Michael Tuttle et al. Thyroid profile →
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

2009 5.1k citations R. Michael Tuttle et al. Thyroid profile →
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce

2006 1.5k citations R. Michael Tuttle et al. Thyroid profile →
Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System

2010 668 citations R. Michael Tuttle, Hernán Tala et al. Thyroid profile →
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

2013 555 citations Alan L. Ho, Ravinder K. Grewal et al. profile →
Consensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid Cancer

2009 426 citations R. Michael Tuttle et al. Thyroid profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Michael Tuttle United States	76	30.7k	17.0k	5.3k	4.6k	4.0k	326	34.1k
Furio Pacini Italy	74	30.5k 1.0×	15.4k 0.9×	5.0k 1.0×	4.5k 1.0×	4.7k 1.2×	258	35.2k
Bryan R. Haugen United States	53	23.6k 0.8×	12.4k 0.7×	3.8k 0.7×	3.7k 0.8×	3.4k 0.9×	159	27.7k
Susan J. Mandel United States	50	24.6k 0.8×	13.0k 0.8×	3.7k 0.7×	2.9k 0.6×	2.3k 0.6×	99	28.0k
Yuri E. Nikiforov United States	82	26.3k 0.9×	9.9k 0.6×	3.2k 0.6×	6.0k 1.3×	6.9k 1.7×	250	32.8k
Martin Schlumberger France	93	39.8k 1.3×	19.9k 1.2×	7.1k 1.4×	5.9k 1.3×	9.0k 2.2×	387	50.2k
Erik K. Alexander United States	52	19.9k 0.6×	8.8k 0.5×	2.6k 0.5×	2.7k 0.6×	1.9k 0.5×	137	23.6k
Rossella Elisei Italy	72	18.4k 0.6×	6.2k 0.4×	2.2k 0.4×	3.4k 0.7×	5.5k 1.4×	370	23.3k
Ernest L. Mazzaferri United States	59	18.2k 0.6×	12.0k 0.7×	2.9k 0.6×	2.6k 0.6×	2.0k 0.5×	303	23.1k
Henning Dralle Germany	73	15.9k 0.5×	13.8k 0.8×	1.4k 0.3×	2.6k 0.6×	4.7k 1.2×	585	26.8k
Ashok R. Shaha United States	87	12.3k 0.4×	14.2k 0.8×	2.2k 0.4×	2.6k 0.6×	7.4k 1.8×	528	26.5k

Countries citing papers authored by R. Michael Tuttle

Since Specialization

Citations

This map shows the geographic impact of R. Michael Tuttle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Michael Tuttle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Michael Tuttle more than expected).

Fields of papers citing papers by R. Michael Tuttle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Michael Tuttle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Michael Tuttle. The network helps show where R. Michael Tuttle may publish in the future.

Co-authorship network of co-authors of R. Michael Tuttle

This figure shows the co-authorship network connecting the top 25 collaborators of R. Michael Tuttle. A scholar is included among the top collaborators of R. Michael Tuttle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Michael Tuttle. R. Michael Tuttle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ibrahim, Abdalla, Ramesh Paudyal, Akash Shah, et al.. (2025). Impact of artificial intelligence-based and traditional image preprocessing and resampling on MRI-based radiomics for classification of papillary thyroid carcinoma. PubMed. 2(1). ubaf006–ubaf006.

Ritter, Amit, et al.. (2025). Comparable Outcomes of Differentiated Thyroid Cancer in Immunocompromised Versus Immunocompetent Patients. The Journal of Clinical Endocrinology & Metabolism. 111(4). 1075–1083. 1 indexed citations

Valero, Cristina, Dauren Adilbay, Victoria Harries, et al.. (2025). A Clinical Nomogram to Predict Survival Outcomes in Patients with Well-Differentiated Thyroid Cancer. Thyroid. 35(4). 397–405.

Ghossein, Ronald, Nora Katabi, Snjezana Doğan, et al.. (2024). Papillary thyroid carcinoma tall cell subtype (PTC‐TC) and high‐grade differentiated thyroid carcinoma tall cell phenotype (HGDTC‐TC) have different clinical behaviour: a retrospective study of 1456 patients. Histopathology. 84(7). 1130–1138. 5 indexed citations

Saliba, Maelle, Bayan Alzumaili, Nora Katabi, et al.. (2022). Clinicopathologic and Prognostic Features of Pediatric Follicular Cell–derived Thyroid Carcinomas. The American Journal of Surgical Pathology. 46(12). 1659–1669. 17 indexed citations

Ho, Alan L., Marek Dedecjus, Lori J. Wirth, et al.. (2022). Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA). Journal of Clinical Oncology. 40(17). 1870–1878. 37 indexed citations

Urken, Mark L., et al.. (2022). Psychological adjustment to initial treatment for low‐risk thyroid cancer: Preliminary study. Head & Neck. 45(2). 439–448. 4 indexed citations

Tuttle, R. Michael, et al.. (2021). Abnormal growth rate of a benign cervical sympathetic chain schwannoma. SHILAP Revista de lepidopterología. 19. 100295–100295. 1 indexed citations

Sherman, Eric J., et al.. (2020). Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies. Thyroid. 30(8). 1112–1119. 19 indexed citations

10.

Xu, Bin, R. Michael Tuttle, Bayan Alzumaili, et al.. (2019). How Many Papillae in Conventional Papillary Carcinoma? A Clinical Evidence-Based Pathology Study of 235 Unifocal Encapsulated Papillary Thyroid Carcinomas, with Emphasis on the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Thyroid. 29(12). 1792–1803. 39 indexed citations

11.

Ibrahimpašić, Tihana, Bin Xu, Iñigo Landa, et al.. (2017). Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence. Clinical Cancer Research. 23(19). 5970–5980. 94 indexed citations

12.

Vaisman, Fernanda, Denise Momesso, Daniel Bulzico, et al.. (2013). Thyroid Lobectomy Is Associated with Excellent Clinical Outcomes in Properly Selected Differentiated Thyroid Cancer Patients with Primary Tumors Greater Than 1 cm. Journal of Thyroid Research. 2013. 1–5. 47 indexed citations

13.

Ghossein, Ronald, Ian Ganly, Agnese Biagini, et al.. (2013). Prognostic Factors in Papillary Microcarcinoma with Emphasis on Histologic Subtyping: A Clinicopathologic Study of 148 Cases. Thyroid. 24(2). 245–253. 51 indexed citations

14.

Sabra, Mona M., Ravinder K. Grewal, Hernán Tala, Steven M. Larson, & R. Michael Tuttle. (2012). Clinical Outcomes Following Empiric Radioiodine Therapy in Patients with Structurally Identifiable Metastatic Follicular Cell–Derived Thyroid Carcinoma with Negative Diagnostic But Positive Post-Therapy ¹³¹ I Whole-Body Scans. Thyroid. 22(9). 877–883. 42 indexed citations

15.

Nixon, Iain J., Monica M. Whitcher, Frank L. Palmer, et al.. (2012). The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid Gland. Thyroid. 22(9). 884–889. 190 indexed citations

16.

Robbins, Richard J., et al.. (2011). Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH. The Journal of Clinical Endocrinology & Metabolism. 96(7). 2105–2111. 70 indexed citations

17.

Tuttle, R. Michael, Hernán Tala, Jatin P. Shah, et al.. (2010). Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System. Thyroid. 20(12). 1341–1349. 668 indexed citations breakdown →

18.

Rivera, Michael, Julio C. Ricarte‐Filho, R. Michael Tuttle, et al.. (2010). Molecular, Morphologic, and Outcome Analysis of Thyroid Carcinomas According to Degree of Extrathyroid Extension. Thyroid. 20(10). 1085–1093. 66 indexed citations

19.

Ricarte‐Filho, Julio C., Mabel Ryder, Dhananjay Chitale, et al.. (2009). Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA , and AKT1. Cancer Research. 69(11). 4885–4893. 420 indexed citations

20.

Robbins, Richard J., Qiang Wan, Ravinder K. Grewal, et al.. (2006). Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning. The Journal of Clinical Endocrinology & Metabolism. 91(2). 498–505. 403 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact